- Healthier is wealthier: “We find that the intervention [to prevent heart disease] significantly increased earnings by 3 percent and family income by 4 percent with no concurrent effect on labor force participation.”
- Can Public Choice explain why health care has been relatively unaffected by inflation? Speculative.
- Your health data might be for sale.
- After learning that McKinsey urged Purdue to “turbocharge” sales of OxyContin (widely blamed for the opioid crisis), we now learn that it has been urging Endo to aggressively market a painkiller that is twice as potent.
- NY Health Department advises users to consume fentanyl “safely.”
Category: Drug Prices & Regulations
Pfizer’s View of its Own Vaccine
Turns out, it is very positive. But in a review of Pfizer CEO Albert Bourla’s book, Moonshot, Robert Kaplan asks:
How transparent has Pfizer been? In the book’s more than 200 pages, one topic is not explored in any real depth—side effects. Although the vaccine is generally regarded as safe, side effects do appear to be more common—and perhaps more severe—than for other widely used vaccines. In the 2020 clinical trial that provided the basis for FDA emergency-use authorization, more than 83% of 18- to 55-year-old participants (in comparison with 14% of those injected with a placebo) reported arm pain after their first shot, and approximately a third had a fever in reaction to their second (in contrast to less than 1% for a placebo).
Friday Links
Thursday Links
HHS says it doesn’t have time to review itself.